@Deme thanks for all this information. The Sprout8 note is overly optimistic, but it contains a lot of very interesting information that I assume came from their conversations with the company. This helps fill in a lot of gaps.
I do still think that there is a significant amount of risk the assay may fail in clinical testing, but if things works then they have some potential. I think it would be a good idea for RHY to undertake some formal market research to ensure they have a market. This would help support the SP during the sensitive time before clinical results are known.
I am putting RHY onto my watch list and if the clinical testing works I may invest.
An opinion on the commercial prospects of RHY, page-12
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.41M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5969 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 5500 | 1 |
View Market Depth
| Last trade - 16.16pm 18/11/2024 (20 minute delay) ? |
| RHY (ASX) Chart |
Day chart unavailable
